Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00133380 · ClinicalTrials.gov registry record · Phase 2
A Study in People With High Cholesterol
A Phase 2 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
NCT00133380 is a Phase 2 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 300 participants.
The verdict
NCT00133380, a Phase 2 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purposes of this study are to determine: * The safety of the study medication and any side effects that might be associated with it * Whether the study medication can help patients with high levels of "bad" cholesterol (low-density lipoprotein-cholesterol \[LDL-C\]), alone or in combination with additional study medication
Interventions
- DRUG placebo
- DRUG atorvastatin
- DRUG PPAR alpha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2005-07 |
| Est. Completion | 2006-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00133380
The ClinicalTrials.gov registry entry for NCT00133380 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00133380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00133380 about?
NCT00133380 is a clinical study titled "A Study in People With High Cholesterol". The purposes of this study are to determine: * The safety of the study medication and any side effects that might be associated with it * Whether the study medication can help patients with high levels of "bad" cholesterol (low-density lipoprotein-cholesterol \[LDL-C\]), alone or in combination wit...
What is the current status of trial NCT00133380?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2005-07. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00133380?
The interventions under investigation include: placebo (DRUG), atorvastatin (DRUG), PPAR alpha (DRUG).
Who is sponsoring clinical trial NCT00133380?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.